Anika Therapeutics (ANIK) Tops Q1 EPS by 45c ; Offers Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/2/2026
- Wall Street closes sharply lower as AI cash burn fears spark tech selloff
- Amazon burns cash, Intel flags weak PC demand as AI boom's costs ripple across markets
- Bitcoin, cryptocurrency prices fall after Binance reports security issue
- Higher yields now hurting AI stock bull as bond markets police capex: BofA
- Oil jumps 2%, settles at 6-month highs on fears of escalation in Iran
Tweet
Share
E-mailGet Alerts ANIK Hot Sheet
Price: $20.95 --0%
EPS Growth %: +950.0%
Financial Fact:
Comprehensive income (loss): 9.26M
Today's EPS Names:
AES, SYRS, ZVOI, More
EPS Growth %: +950.0%
Financial Fact:
Comprehensive income (loss): 9.26M
Today's EPS Names:
AES, SYRS, ZVOI, More
Join SI Premium – FREE
Anika Therapeutics (NASDAQ: ANIK) reported Q1 EPS of $0.27, $0.45 better than the analyst estimate of ($0.18). Revenue for the quarter came in at $29.6 million versus the consensus estimate of $28.11 million.
GUIDANCE:
Anika Therapeutics sees FY2026 revenue of $114-122.5 million, versus the consensus of $117.2 million.
For earnings history and earnings-related data on Anika Therapeutics (ANIK) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tower Semiconductor (TSEM) Misses Q3 EPS by 1c ; Offers Guidance
- Tempus AI, Inc (TEM) Tops Q3 EPS by 6c ; Offers Guidance
- KeyBanc on nVent Electric (NVT): 'Underlying Momentum Accelerating'
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
